Literature DB >> 8544836

Activation of cyclic nucleotide phosphodiesterases in FRTL-5 thyroid cells expressing a constitutively active Gs alpha.

G Nemoz1, C Sette, M Hess, C Muca, L Vallar, M Conti.   

Abstract

The expression of a constitutively activated Gs alpha protein in the rat thyroid cell line FRTL-5 causes an increase in the hormone-independent adenylyl cyclase activity and promotes TSH-independent growth of the cells. In spite of the constitutive activation of the adenylyl cyclase, the basal cAMP levels in these cells are only marginally increased. To define the role of phosphodiesterases (PDEs) in the genesis of this phenotype, cyclic nucleotide hydrolysis was determined in two cell lines expressing a mutated Gs alpha (Q227L). In these cells, the hydrolysis of both cAMP and cGMP was markedly increased in comparison with normal cells. This increase is the result of the activation of different forms of PDEs. Analysis of the cGMP hydrolysis and Ca++/calmodulin stimulation of the PDE activity indicated that the activity of a Ca++/calmodulin-stimulated PDE is increased in both cell lines. In addition, an increase in high-affinity, rolipram-sensitive cAMP-PDE activity was associated in both cell lines with the appearance of a 67-68 kilodalton (kDa) protein that cross-reacts with two antibodies against cAMP-PDEs. This form had the properties of ratPDE3.2/PDE4D2, a cAMP-PDE that is inducible by TSH in wild type cells. That an increase in cAMP-specific, rolipram-sensitive PDE plays a role in the phenotype induced by Q227L Gs alpha was confirmed by measurements of the mitogenic activity. Incubation with rolipram, which had no effect on wild type cells, caused an increase in cAMP levels and further stimulated TSH-independent proliferation in both cell lines carrying the mutation.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8544836     DOI: 10.1210/mend.9.10.8544836

Source DB:  PubMed          Journal:  Mol Endocrinol        ISSN: 0888-8809


  4 in total

1.  Characterization of five different proteins produced by alternatively spliced mRNAs from the human cAMP-specific phosphodiesterase PDE4D gene.

Authors:  G B Bolger; S Erdogan; R E Jones; K Loughney; G Scotland; R Hoffmann; I Wilkinson; C Farrell; M D Houslay
Journal:  Biochem J       Date:  1997-12-01       Impact factor: 3.857

2.  Constitutive expression of Gsα(R201C) in mice produces a heritable, direct replica of human fibrous dysplasia bone pathology and demonstrates its natural history.

Authors:  Isabella Saggio; Cristina Remoli; Emanuela Spica; Stefania Cersosimo; Benedetto Sacchetti; Pamela G Robey; Kenn Holmbeck; Ana Cumano; Alan Boyde; Paolo Bianco; Mara Riminucci
Journal:  J Bone Miner Res       Date:  2014-11       Impact factor: 6.741

3.  Transfer, analysis, and reversion of the fibrous dysplasia cellular phenotype in human skeletal progenitors.

Authors:  Stefania Piersanti; Cristina Remoli; Isabella Saggio; Alessia Funari; Stefano Michienzi; Benedetto Sacchetti; Pamela Gehron Robey; Mara Riminucci; Paolo Bianco
Journal:  J Bone Miner Res       Date:  2010-05       Impact factor: 6.741

4.  PET Imaging of Phosphodiesterase-4 Identifies Affected Dysplastic Bone in McCune-Albright Syndrome, a Genetic Mosaic Disorder.

Authors:  Lora D Weidner; Yuichi Wakabayashi; Louise A Stolz; Michael T Collins; Lori Guthrie; Milalynn Victorino; Joyce Chung; William Miller; Sami S Zoghbi; Victor W Pike; Masahiro Fujita; Robert B Innis; Alison M Boyce
Journal:  J Nucl Med       Date:  2020-04-13       Impact factor: 11.082

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.